Status:
COMPLETED
Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)
Lead Sponsor:
Mayo Clinic
Conditions:
Cardiovascular Risk
Cardiovascular Prevention
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
Cardiovascular (CV) disease is the #1 cause of premature mortality and substantial morbidity in the U.S. Despite clinical guidelines, most clinical interventions are implemented in people at relativel...
Detailed Description
The primary prevention of cardiovascular (CV) events is often more intense in individuals at lower risk and vice versa (the so called "risk-treatment paradox") in part due to unawareness of each perso...
Eligibility Criteria
Inclusion
- Clinician Participants: All clinicians who are affiliated with a participating primary care practice and care for adult patients eligible for CV prevention will be invited to participate.
- Patient Participants: Adult patients (ages 40-75 years) with or without diabetes who have not experienced an atherothrombotic clinical event and receive preventive care at a participating primary care practice will be eligible to participate.
Exclusion
- \- Individuals who do not speak English or have any sort of cognitive deficit that would impact their ability to consent to participate in the study will not be invited to participate.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2025
Estimated Enrollment :
112127 Patients enrolled
Trial Details
Trial ID
NCT04450914
Start Date
May 10 2021
End Date
April 29 2025
Last Update
May 2 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Wellstar Health System
Marietta, Georgia, United States, 30060
2
Mayo Clinic
Rochester, Minnesota, United States, 55905
3
Altru Health System
Grand Forks, North Dakota, United States, 58201
4
VHC Health
Arlington, Virginia, United States, 22205